GPX4 and steatosis: In conclusion, TRIM59 can promote MAFLD steatosis and ferroptosis by enhancing GPX4 ubiquitination, and inhibiting TRIM59 can effectively improve the MAFLD process, so TRIM59 may be a potential target for MAFLD treatment (84).